Rho/ROCK Pathway and Noncoding RNAs: Implications in Ischemic Stroke and Spinal Cord Injury
Ischemic strokes (IS) and spinal cord injuries (SCI) are major causes of disability. RhoA is a small GTPase protein that activates a downstream effector, ROCK. The up-regulation of the RhoA/ROCK pathway contributes to neuronal apoptosis, neuroinflammation, blood-brain barrier dysfunction, astroglios...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/825ffe2bb9ec48eb8412a7d27adc8b16 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:825ffe2bb9ec48eb8412a7d27adc8b16 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:825ffe2bb9ec48eb8412a7d27adc8b162021-11-11T17:03:22ZRho/ROCK Pathway and Noncoding RNAs: Implications in Ischemic Stroke and Spinal Cord Injury10.3390/ijms2221115731422-00671661-6596https://doaj.org/article/825ffe2bb9ec48eb8412a7d27adc8b162021-10-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11573https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Ischemic strokes (IS) and spinal cord injuries (SCI) are major causes of disability. RhoA is a small GTPase protein that activates a downstream effector, ROCK. The up-regulation of the RhoA/ROCK pathway contributes to neuronal apoptosis, neuroinflammation, blood-brain barrier dysfunction, astrogliosis, and axon growth inhibition in IS and SCI. Noncoding RNAs (ncRNAs), such as microRNAs (miRNAs) and long noncoding RNAs (lncRNAs), were previously considered to be non-functional. However, they have attracted much attention because they play an essential role in regulating gene expression in physiological and pathological conditions. There is growing evidence that ROCK inhibitors, such as fasudil and VX-210, can reduce injury in IS and SCI in animal models and clinical trials. Recently, it has been reported that miRNAs are decreased in IS and SCI, while lncRNAs are increased. Inhibiting the Rho/ROCK pathway with miRNAs alleviates apoptosis, neuroinflammation, oxidative stress, and axon growth inhibition in IS and SCI. Further studies are required to explore the significance of ncRNAs in IS and SCI and to establish new strategies for preventing and treating these devastating diseases.Tetsu KimuraYuta HorikoshiChika KuriyagawaYukitoshi NiiyamaMDPI AGarticlestrokespinal cord injuryRhoRho kinasenoncoding RNAapoptosisBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11573, p 11573 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
stroke spinal cord injury Rho Rho kinase noncoding RNA apoptosis Biology (General) QH301-705.5 Chemistry QD1-999 |
spellingShingle |
stroke spinal cord injury Rho Rho kinase noncoding RNA apoptosis Biology (General) QH301-705.5 Chemistry QD1-999 Tetsu Kimura Yuta Horikoshi Chika Kuriyagawa Yukitoshi Niiyama Rho/ROCK Pathway and Noncoding RNAs: Implications in Ischemic Stroke and Spinal Cord Injury |
description |
Ischemic strokes (IS) and spinal cord injuries (SCI) are major causes of disability. RhoA is a small GTPase protein that activates a downstream effector, ROCK. The up-regulation of the RhoA/ROCK pathway contributes to neuronal apoptosis, neuroinflammation, blood-brain barrier dysfunction, astrogliosis, and axon growth inhibition in IS and SCI. Noncoding RNAs (ncRNAs), such as microRNAs (miRNAs) and long noncoding RNAs (lncRNAs), were previously considered to be non-functional. However, they have attracted much attention because they play an essential role in regulating gene expression in physiological and pathological conditions. There is growing evidence that ROCK inhibitors, such as fasudil and VX-210, can reduce injury in IS and SCI in animal models and clinical trials. Recently, it has been reported that miRNAs are decreased in IS and SCI, while lncRNAs are increased. Inhibiting the Rho/ROCK pathway with miRNAs alleviates apoptosis, neuroinflammation, oxidative stress, and axon growth inhibition in IS and SCI. Further studies are required to explore the significance of ncRNAs in IS and SCI and to establish new strategies for preventing and treating these devastating diseases. |
format |
article |
author |
Tetsu Kimura Yuta Horikoshi Chika Kuriyagawa Yukitoshi Niiyama |
author_facet |
Tetsu Kimura Yuta Horikoshi Chika Kuriyagawa Yukitoshi Niiyama |
author_sort |
Tetsu Kimura |
title |
Rho/ROCK Pathway and Noncoding RNAs: Implications in Ischemic Stroke and Spinal Cord Injury |
title_short |
Rho/ROCK Pathway and Noncoding RNAs: Implications in Ischemic Stroke and Spinal Cord Injury |
title_full |
Rho/ROCK Pathway and Noncoding RNAs: Implications in Ischemic Stroke and Spinal Cord Injury |
title_fullStr |
Rho/ROCK Pathway and Noncoding RNAs: Implications in Ischemic Stroke and Spinal Cord Injury |
title_full_unstemmed |
Rho/ROCK Pathway and Noncoding RNAs: Implications in Ischemic Stroke and Spinal Cord Injury |
title_sort |
rho/rock pathway and noncoding rnas: implications in ischemic stroke and spinal cord injury |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/825ffe2bb9ec48eb8412a7d27adc8b16 |
work_keys_str_mv |
AT tetsukimura rhorockpathwayandnoncodingrnasimplicationsinischemicstrokeandspinalcordinjury AT yutahorikoshi rhorockpathwayandnoncodingrnasimplicationsinischemicstrokeandspinalcordinjury AT chikakuriyagawa rhorockpathwayandnoncodingrnasimplicationsinischemicstrokeandspinalcordinjury AT yukitoshiniiyama rhorockpathwayandnoncodingrnasimplicationsinischemicstrokeandspinalcordinjury |
_version_ |
1718432188017410048 |